Table 5.
Overall prostate cancer detection rates based on PSA levels and DRE findings.
| DRE | PSA grp | Incidence | Cancer Outcome |
χ2 (df) | Sig. | |
|---|---|---|---|---|---|---|
| (ng/ml) | Total n | No Cancer | Cancer n (%) | |||
| Abnormal | <4 | 28 | 17 | 11 (39.3) | 492.13 [5] | <0.001 |
| (n=1956) | 4-10 | 244 | 171 | 73 (29.9) | ||
| 10-20 | 385 | 226 | 159 (41.3) | |||
| 20-50 | 427 | 184 | 243 (56.9) | |||
| 50-100 | 271 | 62 | 209 (77.1) | |||
| 100+ | 601 | 33 | 568 (94.5) | |||
| 1956 | 693 | 1263 (64.6) | ||||
| Normal | <4 | 15 | 13 | 2 (13.3) | 115.15 [5] | <0.001 |
| (n=1261) | 4-10 | 490 | 415 | 75 (15.3) | ||
| 10-20 | 378 | 286 | 92 (24.3) | |||
| 20-50 | 255 | 155 | 100 (39.2) | |||
| 50-100 | 81 | 43 | 38 (46.9) | |||
| 100+ | 42 | 12 | 30 (71.4) | |||
| 1261 | 924 | 337 (26.7) | ||||
χ2 =Chi-square df= degrees of freedom n=Sample Sig. = P value